Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Saved in:

Bibliographic Details
Main Authors:	Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-07-01
Series:	Clinical & Experimental Hepatology
Subjects:	hiv/hcv coinfection daa treatment glecaprevir/pibrentasvir bictegravir/emtricitabine/tenofovir alafenamide
Online Access:	https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
by: Hernando Knobel, et al.
Published: (2023-12-01)

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
by: Liwei Zhuang, et al.
Published: (2025-02-01)

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial
by: Barbara Rossetti, et al.
Published: (2024-11-01)

Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis
by: Hsuan-Yu Hung, et al.
Published: (2024-12-01)

Impact of interferon-free regimens in patients with chronic HCV and successfully ablated HCC
by: Amr Maged Mahmoud Rasheed, et al.
Published: (2025-02-01)

Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir
by: Shana Yi, et al.
Published: (2024-12-01)

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
by: Bruno Emond, et al.
Published: (2021-06-01)

Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01)

Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01)

High CD163 Expression on Classical Monocytes Is Associated with Immune Control of HBV Infection in Noncirrhotic Patients
by: Anna Parfieniuk-Kowerda, et al.
Published: (2020-01-01)

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
by: Hussam Al Soub, et al.
Published: (2020-01-01)

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
by: Dorota Zarębska-Michaluk, et al.
Published: (2019-01-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

The Comprehensive Review of Deviated Septum: Anatomy, Diagnosis, and Treatment Approaches
by: Zuzanna Kudas, et al.
Published: (2025-01-01)

Optimization of Distillation Conditions for Improved Recovery of Phthalides from Celery (Apium graveolens L.) Seeds
by: Adam Kokotkiewicz, et al.
Published: (2021-06-01)

A New Preprocessing Method for Diabetes and Biomedical Data Classification
by: Sarbast CHALO, et al.
Published: (2023-01-01)

Review of sustainable temporary housing and reuse strategy for post-disaster architectures: current trends and strategic gaps
by: Berkan Kahvecioğlu, et al.
Published: (2025-01-01)

Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn’s Disease
by: Justyna Lorenc-Góra, et al.
Published: (2025-01-01)

Zasady wykorzystania środków z Programu Rozwoju Obszarów Wiejskich na lata 2014-2020 do termomodernizacji gospodarstw rolnych
by: Agnieszka Huterska, et al.
Published: (2018-03-01)

Poland's Competitive Position in Trade in Agri-Food Products with the United Kingdom – Selected Aspects
by: Justyna Łapińska, et al.
Published: (2017-12-01)

Residual HCV-RNA and Elevated Platelet-to-Lymphocyte Ratio Predict Poor Long-Term Outcomes in Patients with Chronic Hepatitis C After Treatment
by: Anna Wróblewska, et al.
Published: (2024-12-01)

Does Toxoplasma gondii Infection Affect the Levels of IgE and Cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?
by: Joanna Matowicka-Karna, et al.
Published: (2009-01-01)

A study examining the effects of changed rules of wrestling competitions on the muscular damage levels of the elite wrestlers
by: C. Berkan Alpay, et al.
Published: (2014-06-01)

Quantification of Antiretroviral Drug Emtricitabine in Human Plasma by Surface Enhanced Raman Spectroscopy
by: Marguerite R. Butler, et al.
Published: (2024-11-01)

Defensive healthcare practice: systematic review of qualitative evidence
by: James Thomas, et al.
Published: (2024-07-01)

Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults
by: Mohammed Lamorde, et al.
Published: (2012-01-01)

Methylenetetrahydrofolate Reductase Enzyme Mutations and Relationship of Homocysteine Vitamin B12 and Folate Blood Levels
by: Tuba Günebak Şahin, et al.
Published: (2013-04-01)

Multidisciplinary Approach for the Treatment of Horizontal Root-Fractured Maxillary Anterior Teeth
by: Berkan Celikten, et al.
Published: (2014-01-01)

Focal hand dystonia due to hemorrhage of the cervical spinal mass: a case report
by: Pelin Analay, et al.
Published: (2025-01-01)

Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort
by: Hye-Jin Yoo, et al.
Published: (2025-02-01)

Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients
by: Yu-Xuan Song, et al.
Published: (2025-01-01)

Development and Validation of UV-Visible Spectrophotometric Baseline Manipulation Method for Simultaneous Quantitation of Tenofovir Disoproxil Fumarate and Emtricitabine in Pharmaceutical Dosage Form
by: Vishnu P. Choudhari, et al.
Published: (2013-01-01)

CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment
by: Klaudia Bonowicz, et al.
Published: (2025-01-01)

Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures
by: Stolarczyk Mariusz, et al.
Published: (2017-12-01)

Pancytopenia in a 70-Year-Old African-American Male: An Unusual Presentation of a Rare Disease
by: Aibek E. Mirrakhimov, et al.
Published: (2014-01-01)

Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group
by: Ugo Giordano, et al.
Published: (2025-01-01)

Professionalisation and Autonomy of the Occupational Therapist Profession in Poland
by: Cabak Anna, et al.
Published: (2024-12-01)

Seismic Methods in Geothermal Water Resource Exploration: Case Study from Łódź Trough, Central Part of Poland
by: Tomasz Maćkowski, et al.
Published: (2019-01-01)

Dopłaty wyrównawcze do obszarów o niekorzystnych warunkach gospodarowania (ONW) czynnikiem poprawy zyskowności niskodochodowych gospodarstw owczarskich
by: Anna Borecka, et al.
Published: (2009-12-01)

Dopłaty wyrównawcze do obszarów o niekorzystnych warunkach gospodarowania (ONW) czynnikiem poprawy zyskowności niskodochodowych gospodarstw owczarskich
by: Anna Borecka, et al.
Published: (2009-12-01)